Calamos Advisors’s Future Health ESG Corp. Common stock FHLT Stock Holding History

Calamos Advisors’s Portfolio FHLT Stock Details FHLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400,000	Closed	-$4M	–	1361
2022 Q3	$4M	Buy	+400,000	New	+$3.98M	0.02%	759

Other funds holding FHLT

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Calamos Advisors's FHLT Position: Q4 2022 in Review

Calamos Advisors sold out of Future Health ESG Corp. Common stock (FHLT) in Q4 2022, closing a stake of 400,000 shares — an estimated $4M sold.

Calamos Advisors first reported a position in FHLT in Q3 2022 and held it in 1 quarter. The position peaked at $4M in Q3 2022. 10 funds tracked by Wall St. Rank hold FHLT as of Q4 2022.

Calamos Advisors reported no remaining Future Health ESG Corp. Common stock position as of Q4 2022 after selling out during the quarter.
Calamos Advisors sold 400,000 Future Health ESG Corp. Common stock shares in Q4 2022, an estimated $4M.
Calamos Advisors first reported a position in Future Health ESG Corp. Common stock in Q3 2022 and held it in 1 quarter.
Calamos Advisors's Future Health ESG Corp. Common stock position peaked at $4M in Q3 2022.
10 funds tracked by Wall St. Rank held Future Health ESG Corp. Common stock as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.